Government panel backs retaining doorstep medicine delivery rule with tighter checks

A government sub-committee has recommended keeping the 2020 rule permitting doorstep medicine delivery, while strengthening prescription verification and platform compliance. The move would support e-pharmacy and quick-commerce access for rural, elderly and chronic-care consumers.

— Source publishedWed, 9 Sept, 2026, 00:42 IST·First seen Wed, 9 Sept, 2026, 00:53 IST·Source ET Small Business

What happened

Swiggy · Government sub-committee recommends retaining the 2020 doorstep medicine-delivery rule, while enforcing stricter prescription checks and platform

Key facts

  • 2020
  • GSR 220(E)
  • Rule 65(e)
  • 1945
  • April 2025
  • May 2025

Why this matters

Strategic buyers should prioritize e-pharmacy, prescription-validation and healthcare-logistics targets with robust regulatory infrastructure, as stricter rules could accelerate consolidation around compliant players.

What to watch

  • Publication of the final government notification, including effective date and whether the recommendation becomes binding.
  • Specific requirements for prescription digitization, pharmacist supervision, patient authentication, record retention and platform liability.
  • Rules covering scheduled drugs, antibiotics, narcotics, refrigerated medicines and repeat-refill dispensing.
  • State-level licensing, inspection and enforcement actions against e-pharmacy or quick-commerce operators.
  • Major platforms announcing pharmacy partnerships, compliance investments, assortment restrictions or expansion into chronic-care subscriptions.
  • Evidence of prescription rejection rates, fulfillment delays or higher unit economics after new checks are implemented.
  • Build prescription-verification workflows covering e-prescriptions, repeat prescriptions, pharmacist review, patient identity checks and auditable records.
  • Segment assortment by regulatory risk, explicitly excluding or tightly controlling scheduled, cold-chain and high-abuse medicines.
  • Use chronic-care refills, elderly-care subscriptions and rural pharmacy partnerships as priority growth wedges rather than relying only on urgent-delivery demand.
  • Evaluate acquisition, white-label fulfillment or compliance-platform partnerships with licensed local pharmacies to expand coverage with lower regulatory exposure.
  • Prepare consumer messaging around verified prescriptions, licensed pharmacists, secure handling and delivery traceability to convert stricter rules into a trust advantage.